Eli Lilly caps out-of-pocket cost for insulin at $35 a month
Headline from Health Care Finance News, on the newest of 2 developments
The drugmaker, the Biden administration and organizations are calling on other companies to do the same.
Health Care Finance News's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Drugmaker Eli Lilly says it's cutting insulin prices by 70%
Headline from Fox5 Atlanta ·
Newest
Eli Lilly caps out-of-pocket cost for insulin at $35 a month
Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay when they fill prescriptions.
Eli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on the costs they pay to fill prescriptions. The moves promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin.
An insulin maker is cutting its prices. Eli Lilly, one of the three makers of insulin products in the United States, is also making other moves toward affordability for people with diabetes.
Eli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on costs they pay to fill prescriptions.
After Eli Lilly announced that they are capping patient out-of-pocket insulin costs at $35. President Biden urged other insulin manufacturers to follow.
US pharmaceutical giant Eli Lilly announced Wednesday it was cutting the cost of its most commonly prescribed insulins by 70 percent after years of soaring prices that hit millions of Americans living…
President Biden hailed Eli Lilly & Co. on Wednesday for capping out-of-pocket costs for insulin at $35, a move that aligns with a key priority for the administration.
Drugmaker Eli Lilly & Co. on Tuesday said it will cut prices of its most commonly prescribed insulins by 70% and cap monthly prices at $35 per month at certain retail pharmacies for people who have private insurance.
NPR's Ailsa Chang talks with Eli Lilly CEO David Ricks about the company's move to reduce prices on some older insulins and cap how much people have to pay out of their own pocket.
The White House said Eli Lilly’s move to cap out-of-pocket costs for insulin at $35 for patients shows why Republicans should stop trying to repeal the Inflation Reduction Act.
Eli Lilly and Co. announced Wednesday the company plans to cut the price of commonly used insulin by 70%, capping out-of-pocket costs at $35 per month.
By Jen Christensen and Betsy Klein, CNN Eli Lilly announced Wednesday a series of price cuts that would lower the price of the most commonly used forms of its insulin 70% and said it will automatically cap out-of-pocket insulin costs at $35 for people who have private insurance and use participating…
(CNN) — Indianapolis-based Eli Lilly announced Wednesday a series of price cuts that would lower the price of the most commonly used forms of its insulin 70% and said it will automatically cap out-of-pocket insulin costs at $35 for people who have private insurance and use participating pharmacies.
Drugmaker Eli Lilly said Wednesday it would lower the prices of its most frequently used insulins by 70% and expand a program to cap out-of-pocket costs for patients at $35.
The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Eli Lilly announced Wednesday that it will immediately cap out-of-pocket costs for insulin at $35. It is a welcome relief to millions of Americans who depend on insulin to survive.
Showing the first 25 of 35 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
